Cargando…

Aberrant expression of ADAM9 in ovarian cancer and its clinical significance

BACKGROUND: The oncogene a disintegrin and metalloproteinase 9 (ADAM9) was up‐regulated in ovarian cancer tissues, and the present study aims to explore the potential diagnostic and prognostic value of ADAM9 in ovarian cancer (OC). METHODS: A total of 30 paired fresh OC tumor tissues and the paired‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ting, Yuan, Donglan, Lin, Mei, Zhu, Dandan, Xu, Ning, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171348/ https://www.ncbi.nlm.nih.gov/pubmed/31793719 http://dx.doi.org/10.1002/jcla.23136

Ejemplares similares

Aberrant ADAM10 expression correlates with osteosarcoma progression
por: Zhao, Ren, et al.
Publicado: (2014)

Elevated Expression of miR-296 in Human Placentas and Serum Samples From Pregnancies With Preeclampsia
por: Zhu, Dandan, et al.
Publicado: (2023)

ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells
por: Li, Ya-qing, et al.
Publicado: (2013)

ADAM9 Expression in Uterine Cervical Cancer and Its Associated Factors
por: Isa, Seoparjoo Azmel Mohd, et al.
Publicado: (2019)

Role of lncRNA-ATB in ovarian cancer and its mechanisms of action
por: Yuan, Donglan, et al.
Publicado: (2020)

Evolution of Vertebrate Adam Genes; Duplication of Testicular Adams from Ancient Adam9/9-like Loci
por: Bahudhanapati, Harinath, et al.
Publicado: (2015)

Stage‐dependent involvement of ADAM10 and its significance in epileptic seizures
por: Zhou, Xu, et al.
Publicado: (2019)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

ADAM9 is over‐expressed in human ovarian clear cell carcinomas and suppresses cisplatin‐induced cell death
por: Ueno, Mari, et al.
Publicado: (2018)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Aberrant expression of Arpin in human breast cancer and its clinical significance
por: Liu, Xiangping, et al.
Publicado: (2015)

Aberrant expression of CCDC69 in breast cancer and its clinicopathologic significance
por: Li, Jinjiao, et al.
Publicado: (2021)

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma
por: Liu, Yi, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer
por: Li, Tao, et al.
Publicado: (2017)

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020)

Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer
por: Han, Lin-Lin, et al.
Publicado: (2013)

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021)

Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3
por: Zhu, Dandan, et al.
Publicado: (2019)

Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer
por: ZHONG, XINWEN, et al.
Publicado: (2014)

LncRNA-ATB Promotes the Tumorigenesis of Ovarian Cancer via Targeting miR-204-3p
por: Yuan, Donglan, et al.
Publicado: (2020)

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Aberrant Expression of the Long Non-coding RNA GHRLOS and Its Prognostic Significance in Patients with Colorectal Cancer
por: Wu, Shuangjie, et al.
Publicado: (2017)

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017)

Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma
por: Chen, Jia, et al.
Publicado: (2019)

Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cells
por: HU, LI, et al.
Publicado: (2013)

Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
por: Ma, Jing, et al.
Publicado: (2019)

Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
por: Sammel, Martin, et al.
Publicado: (2019)

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
por: Wu, Yan, et al.
Publicado: (2021)

Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
por: Prinzen, Claudia, et al.
Publicado: (2009)

ADAM17 inhibition enhances platinum efficiency in ovarian cancer
por: Hedemann, Nina, et al.
Publicado: (2018)

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
por: Marcello, Elena, et al.
Publicado: (2019)

LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
por: Zhao, Yinling, et al.
Publicado: (2021)

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer
por: Fu, Yunfeng, et al.
Publicado: (2014)

CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17
por: Liu, Jie, et al.
Publicado: (2019)

The metalloproteinase ADAM10 requires its activity to sustain surface expression
por: Seifert, Anke, et al.
Publicado: (2020)

Aberrant expression of HIF3A in plasma of patients with non‐small cell lung cancer and its clinical significance
por: Wei, Liang, et al.
Publicado: (2021)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Silencing the ADAM9 Gene through CRISPR/Cas9 Protects Mice from Alcohol-Induced Acute Liver Injury
por: Zhang, Yong-Yong, et al.
Publicado: (2022)

Cosmosiin Increases ADAM10 Expression via Mechanisms Involving 5’UTR and PI3K Signaling
por: Min, Zhuo, et al.
Publicado: (2018)

ADAM10 modulates SOX9 expression via N1ICD during chondrogenesis at the cranial base
por: Fu, Runqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dt45esie3souaoduht8hr0t86o